Liberation Labs, a New York City-based provider of precision fermentation, is lining up as much as $75 million in financing, which includes a Series A round, CEO Mark Warner tells Axios exclusively.
Why it matters: The startup is betting a known technology can be scaled to produce animal-free food ingredients such as bioidentical versions of egg and dairy proteins.
